Chronic kidney disease and atrial fibrillation

Heart Rhythm

Volumn 9, Issue 12, 2012, Pages 2032-2033

  Linz, Dominik ^a   Neuberger, Hans Ruprecht ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTIOXIDANT; C REACTIVE PROTEIN; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEIN; PROTEIN P47PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SODIUM ZINC DIHYDROLIPOYLHISTIDINATE; UNCLASSIFIED DRUG;

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MORBIDITY; NONHUMAN; NOTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REFRACTORY PERIOD;

EID: 84870468339     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.08.024     Document Type: Editorial

References (15)

1. EZ Soliman, RJ Prineas, AS Go et al. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC) Am Heart J 159 2010 1102 1107
2. T Horio, Y Iwashima, K Kamide et al. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients J Hypertens 28 2010 1738 1744
3. N. Fukunaga, N. Takahashi, S. Hagiwara et al. Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress Heart Rhythm 9 2012 2023 2031
4. U Schotten, S Verheule, P Kirchhof, A. Goette Pathophysiological mechanisms of atrial fibrillation: a translational appraisal Physiol Rev 91 2011 265 325
5. JC Reil, M Hohl, M Oberhofer et al. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling Cardiovasc Res 87 2010 485 493
6. A Goette, T Staack, C Röcken et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation J Am Coll Cardiol 35 2000 1669 1677
7. I Savelieva, N Kakouros, A Kourliouros, AJ. Camm Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention Europace 13 2011 610 625
8. JC Reil, M Hohl, S Selejan et al. Aldosterone promotes atrial fibrillation Eur Heart J 2011
9. RB Schnabel, LM Sullivan, D Levy et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study Lancet 373 2009 739 745
10. SC Choisy, LA Arberry, JC Hancox, AF. James Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts Hypertension 49 2007 498 505
11. DH Lau, L Mackenzie, DJ Kelly et al. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model Heart Rhythm 7 2010 1282 1290
12. HR Neuberger, U Schotten, S Verheule et al. Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat Circulation 111 2005 30 37
13. GF DiBona, UC. Kopp Neural control of renal function Physiol Rev 77 1997 75 197
14. Symplicity HTN-2 Investigators, MD Esler, H Krum et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 2010 1903 1909
15. D Linz, F Mahfoud, U Schotten et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea Hypertension 60 2012 172 178